Abstracts Archive - Page 230 of 1683 - ATC Abstracts

2021 American Transplant Congress
Predictors of Severe Covid-19 in Kidney Transplant Recipients in the First and Second Waves: Analysis of the Spanish Registry
M. Crespo¹, A. Mazuecos², I. Pérez-Flores³, F. Moreso⁴, A. Andrés⁵, C. Jimenez⁶, M. Molina⁷, C. Canal⁸, L. Sánchez-Cámara⁹, S. Zárraga¹⁰, M. Ruiz Fuentes¹¹, M. Aladrén¹², E. Melilli¹³, V. López¹⁴, E. Sanchez¹⁵, J. Pascual for Spanish Nephro Society Covid-Registry¹
¹Nephrology, Hospital del Mar, Barcelona, Spain, ²Nephrology, Hospital Puerta del Mar, Cadiz, Spain, ³Nephrology, Hospital Clinico San Carlos, Madrid, Spain, ⁴Nephrology, Hospital Valle Hebrón, Barcelona, Spain, ⁵Nephrology, Hospital 12 Octubre, Madrid, Spain, ⁶Nephrology, Hospital La Paz, Madrid, Spain, ⁷Nephrology, Hospital Germans Trias i Pujol, Barcelona, Spain, ⁸Nephrology, Fundacio Puigvert, Barcelona, Spain, ⁹Nephrology, Hospital Gregorio Marañón, Madrid, Spain, ¹⁰Nephrology, Hospital de Cruces, Bilbao, Spain, ¹¹Nephrology, Hospital Virgen de las Nieves, Granada, Spain, ¹²Nephrology, Hospital Miguel Servet, Zaragoza, Spain, ¹³Nephrology and Kidney Transplantation, Hospital de Bellvitge, Barcelona, Spain, ¹⁴Nephrology, Hospital Regional de Málaga, Malaga, Spain, ¹⁵Nephrology, Hospital de Cabueñes, Gijon, Spain
*Purpose: To better know the impact and characteristics of Covid-19 in renal patients, the Spanish Society of Nephrology set up a voluntary registry in March,…
2021 American Transplant Congress
Characterizing Kidney Transplant Recipients with SARS-CoV-2: An Academic Single Center Experience
S. Nahi, A. Shetty, S. Tanna, J. Leventhal
Northwestern University, Chicago, IL
*Purpose: Kidney transplant (KTx) recipients are a unique cohort in regard to SARS-CoV-2 susceptibility and clinical course, owing to their immunosuppressed state and propensity for…
2021 American Transplant Congress
Outcomes of Simultaneous Pancreas-Kidney Transplants from Donation After Circulatory Death Donors in the UK: A National Registry Analysis
N. Karydis¹, M. Ibrahim², C. Counter², J. Casey³, P. Friend⁴, C. Watson⁵, C. Callaghan¹
¹Nephrology and Transplantation, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom, ²NHS Blood and Transplant, Bristol, United Kingdom, ³Transplant Unit, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom, ⁴Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom, ⁵Department of Surgery, Addenbrooke's Hospital and Cambridge NIHR Biomedical Research Campus, Cambridge, United Kingdom
*Purpose: The UK is a world leader in the use of pancreases from donation after circulatory death (DCD) donors. However, there is a perception that…
2021 American Transplant Congress
Insulin Secretion and Insulin Resistance Trajectories Over 1 Year After Kidney Transplantation: A Multicenter Prospective Cohort Study
B. Jun Bae, C. Oh
Department of Surgery, Ajou University Medical School, Suwon, Korea, Republic of
*Purpose: We investigated the changing patterns of insulin secretion and resistance and risk factors contributing to the development of post-transplant diabetes mellitus (PTDM) in kidney…
2021 American Transplant Congress
Cognition After Belatacept Conversion (CAB) Trial
W. Asch¹, K. Belfield², V. Do², E. Cohen¹
¹Yale University, New Haven, CT, ²Yale New Haven Hospital, New Haven, CT
*Purpose: Extensive adverse effect profiles including neurotoxicity, manifesting as short-term memory loss, make CNIs less desirable despite their efficacy preventing acute rejection and increasing graft…
2021 American Transplant Congress
Intensive Blood Pressure Control Preserves Kidney Allograft Function
K. A. Agarwal¹, U. K. Agarwal², G. S. Silva³, K. J. Pollick³, M. Pavlakis¹
¹Transplant Institute, Beth Israel Deaconess Medical Center, Boston, MA, ²Biostatistics consultant, Boston, MA, ³Beth Israel Deaconess Medical Center, Boston, MA
*Purpose: Kidney transplant recipients (KTRs) are at higher risk of major adverse cardiovascular events compared to the general population, with HTN being a crucial risk…
2021 American Transplant Congress
Growth Differentiation Factor 15 Predictor Value is Superior to Troponin I in the Evaluation of Kidney Transplant Candidates
M. de Cos Gomez¹, M. Garcia Unzueta², A. Benito Hernandez¹, J. Mazon Ruiz¹, M. Perez Arnedo¹, A. Aguilera Fernandez¹, R. Valero San Cecilio¹, J. Ruiz San Millan¹, E. Rodrigo Calabia¹
¹Nephrology, Marques de Valdecilla University Hospital - IDIVAL, Santander, Spain, ²Clinical Analysis, Marques de Valdecilla University Hospital - IDIVAL, Santander, Spain
*Purpose: Pretransplant cardiac troponin I (cTNI) has demonstrated its predictor value of survival after kidney transplant in previous studies. Growth differentiation factor 15 (GDF-15) is…
2021 American Transplant Congress
Liver and Kidney Transplantation During the Covid-19 Pandemic Period: A Single Center Experience
M. Haberal¹, E. Karakaya¹, A. Akdur¹, E. Ayvazoglu Soy¹, F. Ozcay², E. Baskin³, S. Boyacioglu⁴, A. Torgay⁵, S. Yildirim¹, G. Moray¹, F. Yarbug Karakayali¹
¹Division of Transplantation, Department of General Surgery, Baskent University, Ankara, Turkey, ²Department of Pediatric Gastroenterology, Baskent University, Ankara, Turkey, ³Department of Pediatric Nephrology, Baskent University, Ankara, Turkey, ⁴Department of Gastroenterology, Baskent University, Ankara, Turkey, ⁵Department of Anaesthesiology, Baskent University, Ankara, Turkey
*Purpose: Introduction: Beginning of this year, when the Covid-19 pandemic has first started, it had the immediate effect of severely reducing living and deceased organ…
2021 American Transplant Congress
Steroid-free Immunosuppression in Heart-Kidney Transplant Patients: Is It Safe?
R. Skorka, J. Patel, M. Kittleson, N. Patel, T. Singer-Englar, A. Velleca, B. Azarbal, D. Chang, E. Kransdorf, L. Czer, D. Megna, J. A. Kobashigawa
Cedars-Sinai Smidt Heart Institute, Los Angeles, CA
*Purpose: Simultaneous heart and kidney transplantation (sHKTx) has increased in numbers over the past 10 years. There are reports that the kidney protects the heart…
2021 American Transplant Congress
The Impact of 4-weeks of Supervised Exercise on Frailty and Lower Extremity (LE) Function in Patients with Advanced Chronic Kidney Disease (CKD)
E. Lorenz, L. Hickson, R. Weatherly, K. Thompson, M. Hogan, C. Kennedy
Mayo Clinic, Rochester, MN
*Purpose: Although frailty is a modifiable risk factor for morbidity and mortality among kidney transplant (KT) candidates, the optimal duration of effective prehabilitation interventions is…